Azeria Therapeutics
Azeria Therapeutics is the world’s first pioneer factor drug discovery company.
Total raised
€36M
€36,160,000
Funding rounds
1
Investors
1
distinct backers
Active since
2019-09
latest 2019-09
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood18
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-10-01 | Series B | €36M | Syncona Partners LLP | View deal → |